EPO and cancer: In non-smokers, higher sTfR and EPO were associated with increased overall and kidney cancer.<h4>Conclusion</h4>These findings underscore the putative roles of iron metabolism and EPO in cancer, with consistently decreased risks associated with elevated hepcidin levels, particularly among women and individuals with lower BMI.